J&J’s Combo Oral Contraceptive Could Stand Out Against Competition
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson's proposal for an oral contraceptive/ folic acid combination represents an unusual case of taking a concept before an FDA advisory committee prior to any substantive in-house development